Matches in Nanopublications for { ?s ?p "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP241266.RASmZVaYzLpZyX8vXn5q2FdQkEAiqu2RmjexAftf_clLI130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241266.RASmZVaYzLpZyX8vXn5q2FdQkEAiqu2RmjexAftf_clLI130_provenance.
- NP240516.RAtMHofwSoBvRwmsTWcWkiMVuBQ7mh_0Vzfea4y9CBjus130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240516.RAtMHofwSoBvRwmsTWcWkiMVuBQ7mh_0Vzfea4y9CBjus130_provenance.
- NP1158393.RAAor3pzFa-VSa-77olmRkS3LqrB_8fS-ewjjAHkBBX8Q130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158393.RAAor3pzFa-VSa-77olmRkS3LqrB_8fS-ewjjAHkBBX8Q130_provenance.
- NP1158391.RAu5D6xzj41W_yjVGgjLcD83iEkB1vtDqXPL8n8hApsuU130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158391.RAu5D6xzj41W_yjVGgjLcD83iEkB1vtDqXPL8n8hApsuU130_provenance.
- NP1158394.RAqlv6PEAm4NUX7BpnjLoJGatjn14ibY2ZEKC5MUIRf8w130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158394.RAqlv6PEAm4NUX7BpnjLoJGatjn14ibY2ZEKC5MUIRf8w130_provenance.
- NP1158395.RAoz4iz5ByKM0pCiyeuUxt2N3I7HY_6Em4IbLFO-LcxPk130_assertion description "[Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158395.RAoz4iz5ByKM0pCiyeuUxt2N3I7HY_6Em4IbLFO-LcxPk130_provenance.